Kurma Partners is a European venture capital firm focused on funding healthcare and biotechnology companies. They invest across various stages of maturity, from company creation to capital expansion, emphasizing a strong network of partners with leading European academic research institutions. Their strategy involves transforming disruptive scientific discoveries into cutting-edge medicines or medical devices aimed at diagnosing and treating patients with severe diseases and high unmet medical needs. The firm actively works with research teams early on to validate discoveries, bringing together healthcare industry experts and experienced entrepreneurs to build high-tech companies. They provide initial capital/funding and invite other investors to participate. They support early-stage companies by offering expertise and their network. Kurma Partners is committed to sustainable development and adheres to established ESG practices. They aim to build the healthcare industry of tomorrow by collaborating with leading European research centers.
Bevorzugte Reifephase für die erste Finanzierung.
Healthcare, Biotechnology, Pharmaceuticals, Medical Devices
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
